We are live on ! Find out more
Rockefeller Capital Management

Rockefeller Capital Management Portfolio holdings

AUM $56.4B
1-Year Est. Return 24.96%
This Fund
S&P 500
This Quarter Est. Return
+7.55%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
AUM
$17.8B
AUM Growth
+$2.97B
Cap. Flow
+$1.92B
Cap. Flow %
10.82%
Top 10 Hldgs %
20.72%
Holding
3,755
New
435
Increased
1,757
Reduced
754
Closed
214

Top Sells

Rank Stock Value
1
AFL icon
Aflac
AFL
+$122M
2
CERN
Cerner Corp
CERN
+$79.8M
3
MSFT icon
Microsoft
MSFT
+$76.7M
4
AEM icon
Agnico Eagle Mines
AEM
+$60.1M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$47.2M

Sector Composition

Rank Sector Weight
1 Technology 20.15%
2 Financials 14.33%
3 Healthcare 12.64%
4 Consumer Discretionary 8.27%
5 Industrials 6.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGNA
3326
DELISTED
TEGNA Inc
TGNA
$1K ﹤0.01%
72
-145
-67% -$2.85K
THR
3327
DELISTED
Thermon Group Holdings
THR
$1K ﹤0.01%
+61
New +$1.14K
UEIC icon
3328
Universal Electronics
UEIC
$60.6M
$1K ﹤0.01%
+30
New +$1.56K
VNET
3329
VNET Group
VNET
$2B
$1K ﹤0.01%
+58
New +$1.48K
WAFD icon
3330
WaFd
WAFD
$2.77B
$1K ﹤0.01%
58
-344
-86% -$11.2K
WING icon
3331
Wingstop
WING
$3.18B
$1K ﹤0.01%
12
+3
+33% +$432
WIT icon
3332
Wipro
WIT
$19.7B
$1K ﹤0.01%
338
-46,894
-99% -$175K
WK icon
3333
Workiva
WK
$3.38B
$1K ﹤0.01%
11
YCBD icon
3334
cbdMD
YCBD
$5.94M
$1K ﹤0.01%
1
ZVRA icon
3335
Zevra Therapeutics
ZVRA
$702M
$1K ﹤0.01%
125
-100
-44% -$1.07K
NVRO
3336
DELISTED
NEVRO CORP.
NVRO
$1K ﹤0.01%
+8
New +$1.25K
ZUO
3337
DELISTED
Zuora, Inc.
ZUO
$1K ﹤0.01%
100
SILK
3338
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$1K ﹤0.01%
25
+14
+127% +$713
NTG
3339
DELISTED
Tortoise Midstream Energy Fund, Inc. Common Stock
NTG
$1K ﹤0.01%
63
+1
+2% +$29
SP
3340
DELISTED
SP Plus Corporation
SP
$1K ﹤0.01%
38
-204
-84% -$6.68K
FUV
3341
DELISTED
Arcimoto, Inc. Common Stock
FUV
$1K ﹤0.01%
4
KRTX
3342
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1K ﹤0.01%
+9
New +$1.05K
NEPT
3343
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$1K ﹤0.01%
1
ARGO
3344
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$1K ﹤0.01%
33
-68
-67% -$3.66K
SYNH
3345
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$1K ﹤0.01%
18
ISEE
3346
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$1K ﹤0.01%
+300
New +$1.94K
MNTV
3347
DELISTED
Momentive Global Inc. Common Stock
MNTV
$1K ﹤0.01%
76
+52
+217% +$1.01K
ASAP
3348
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$1K ﹤0.01%
+50
New +$2.27K
IPOD
3349
DELISTED
Social Capital Hedosophia Holdings Corp. IV
IPOD
$1K ﹤0.01%
150
FST
3350
DELISTED
FAST Acquisition Corp.
FST
$1K ﹤0.01%
+97
New +$1.2K

Similar funds

Rockefeller Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Rockefeller Capital Management held 3,755 positions worth $17.8B, up 20% from $14.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Rockefeller Capital Management deployed $1.92B of net new capital in Q2 2021, opening 435 new positions and adding to 1,757 existing holdings. Its largest new stake was Mueller Industries: 1,424,220 shares worth $15.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Aflac, an estimated $122M trimmed.

  • Rockefeller Capital Management's largest Q2 2021 buy was Mueller Industries: 1,424,220 shares worth $15.4M.
  • Rockefeller Capital Management added most to Coherent in Q2 2021, an estimated $66.3M increase.
  • Rockefeller Capital Management's biggest Q2 2021 reduction was Aflac, cutting an estimated $122M.
  • Rockefeller Capital Management fully exited NIC Inc in Q2 2021, selling an estimated $30.3M.
  • Rockefeller Capital Management's ten largest holdings make up 21% of its $17.8B portfolio in Q2 2021.
  • Rockefeller Capital Management opened 435 new positions and closed 214 in Q2 2021.
  • Rockefeller Capital Management's portfolio value rose 20% quarter-over-quarter to $17.8B.

Based on Rockefeller Capital Management's 13F filing for Q2 2021, filed 10 Aug 2021.